Orally consumed ginger and human health: an umbrella review.
Zingiber officinale
chronic disease
gastrointestinal conditions
ginger
pain
umbrella review
Journal
The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027
Informations de publication
Date de publication:
07 06 2022
07 06 2022
Historique:
received:
06
07
2021
accepted:
04
02
2022
pubmed:
12
2
2022
medline:
9
6
2022
entrez:
11
2
2022
Statut:
ppublish
Résumé
Emerging evidence supports the health benefits of ginger for a range of conditions and symptoms; however, there is a lack of synthesis of literature to determine which health indications are supported by quality evidence. In this umbrella review of systematic reviews we aimed to determine the therapeutic effects and safety of any type of ginger from the Zingiber family administered in oral form compared with any comparator or baseline measures on any health and well-being outcome in humans. Five databases were searched from inception to April 2021. Review selection and quality were assessed in duplicate using the Assessment of Multiple Systematic Reviews-2 (AMSTAR-2) checklist and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) method, with results presented in narrative form. Twenty-four systematic reviews were included with 3% overlap of primary studies. The strongest evidence was found for the antiemetic effects of ginger in pregnant women (effect size: large; GRADE: high), analgesic effects for osteoarthritis (effect size: small; GRADE: high), and glycemic control (effect size: none to very large; GRADE: very low to moderate). Ginger also had a statistically significant positive effect on blood pressure, weight management, dysmenorrhea, postoperative nausea, and chemotherapy-induced vomiting (effect size: moderate to large; GRADE: low to moderate) as well as blood lipid profile (effect size: small; GRADE: very low) and anti-inflammatory and antioxidant biomarkers (effect size: unclear; GRADE: very low to moderate). There was substantial heterogeneity and poor reporting of interventions; however, dosage of 0.5-3 g/d in capsule form administered for up to 3 mo was consistently reported as effective. Dietary consumption of ginger appears safe and may exert beneficial effects on human health and well-being, with greatest confidence in antiemetic effects in pregnant women, analgesic effects in osteoarthritis, and glycemic control. Future randomized controlled and dose-dependent trials with adequate sample sizes and standardized ginger products are warranted to better inform and standardize routine clinical prescription.
Sections du résumé
BACKGROUND
Emerging evidence supports the health benefits of ginger for a range of conditions and symptoms; however, there is a lack of synthesis of literature to determine which health indications are supported by quality evidence.
OBJECTIVES
In this umbrella review of systematic reviews we aimed to determine the therapeutic effects and safety of any type of ginger from the Zingiber family administered in oral form compared with any comparator or baseline measures on any health and well-being outcome in humans.
METHODS
Five databases were searched from inception to April 2021. Review selection and quality were assessed in duplicate using the Assessment of Multiple Systematic Reviews-2 (AMSTAR-2) checklist and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) method, with results presented in narrative form.
RESULTS
Twenty-four systematic reviews were included with 3% overlap of primary studies. The strongest evidence was found for the antiemetic effects of ginger in pregnant women (effect size: large; GRADE: high), analgesic effects for osteoarthritis (effect size: small; GRADE: high), and glycemic control (effect size: none to very large; GRADE: very low to moderate). Ginger also had a statistically significant positive effect on blood pressure, weight management, dysmenorrhea, postoperative nausea, and chemotherapy-induced vomiting (effect size: moderate to large; GRADE: low to moderate) as well as blood lipid profile (effect size: small; GRADE: very low) and anti-inflammatory and antioxidant biomarkers (effect size: unclear; GRADE: very low to moderate). There was substantial heterogeneity and poor reporting of interventions; however, dosage of 0.5-3 g/d in capsule form administered for up to 3 mo was consistently reported as effective.
CONCLUSIONS
Dietary consumption of ginger appears safe and may exert beneficial effects on human health and well-being, with greatest confidence in antiemetic effects in pregnant women, analgesic effects in osteoarthritis, and glycemic control. Future randomized controlled and dose-dependent trials with adequate sample sizes and standardized ginger products are warranted to better inform and standardize routine clinical prescription.
Identifiants
pubmed: 35147170
pii: S0002-9165(22)00277-5
doi: 10.1093/ajcn/nqac035
pmc: PMC9170469
doi:
Substances chimiques
Analgesics
0
Antiemetics
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1511-1527Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.
Références
J Strength Cond Res. 2015 Oct;29(10):2980-95
pubmed: 26200194
Food Nutr Res. 2016 Nov 01;60:32613
pubmed: 27806832
BMC Complement Altern Med. 2017 Nov 14;17(1):489
pubmed: 29137614
J Clin Epidemiol. 2011 Apr;64(4):380-2
pubmed: 21185693
Int J Prev Med. 2018 Aug 30;9:75
pubmed: 30319738
Pain Med. 2015 Dec;16(12):2243-55
pubmed: 26177393
Pain Physician. 2020 Mar;23(2):E151-E161
pubmed: 32214292
Complement Ther Clin Pract. 2011 May;17(2):71-5
pubmed: 21457894
Phytother Res. 2018 Apr;32(4):577-585
pubmed: 29193411
Biomed Res Int. 2019 Dec 20;2019:5370823
pubmed: 31930125
J Matern Fetal Neonatal Med. 2022 Jan;35(1):187-196
pubmed: 31937153
Cytokine. 2020 Nov;135:155224
pubmed: 32763761
Clin Res Pr Drug Regul Aff. 1988;6(2):129-36
pubmed: 11538042
Phytother Res. 2019 Jun;33(6):1639-1647
pubmed: 30972845
Foods. 2019 May 30;8(6):
pubmed: 31151279
Phytother Res. 2021 Feb;35(2):711-742
pubmed: 32954562
Cochrane Database Syst Rev. 2016 Mar 22;3:CD002124
pubmed: 27000311
Phytother Res. 2019 Aug;33(8):1957-1965
pubmed: 31225678
PLoS One. 2015 Oct 21;10(10):e0141119
pubmed: 26488162
Am J Emerg Med. 2021 Aug;46:567-571
pubmed: 33293189
Complement Ther Clin Pract. 2021 May;43:101362
pubmed: 33740590
Nutrients. 2020 Jan 06;12(1):
pubmed: 31935866
Cureus. 2021 Mar 6;13(3):e13743
pubmed: 33842121
J BUON. 2013 Oct-Dec;18(4):1048-51
pubmed: 24344037
Front Microbiol. 2021 Feb 23;11:576061
pubmed: 33708178
Can J Diabetes. 2018 Apr;42 Suppl 1:S154-S161
pubmed: 29650089
Ther Adv Musculoskelet Dis. 2021 Jun 18;13:1759720X211022149
pubmed: 34211591
Osteoarthritis Cartilage. 2015 Jan;23(1):13-21
pubmed: 25300574
J Med Assoc Thai. 2010 Mar;93(3):366-72
pubmed: 20420113
Crit Rev Food Sci Nutr. 2019;59(11):1753-1766
pubmed: 29393665
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Food Chem Toxicol. 2008 Feb;46(2):409-20
pubmed: 17950516
J Travel Med. 1994 Dec 1;1(4):203-206
pubmed: 9815340
BMJ. 2017 Sep 21;358:j4008
pubmed: 28935701
Crit Rev Food Sci Nutr. 2017 Jan 2;57(1):141-146
pubmed: 25848702
J Acad Nutr Diet. 2019 Dec;119(12):2055-2068
pubmed: 31519467
Nat Med. 2019 Dec;25(12):1822-1832
pubmed: 31806905
Complement Med Res. 2022;29(1):67-73
pubmed: 33789272
BMC Complement Altern Med. 2019 Jan 5;19(1):5
pubmed: 30611269
Curr Ther Res Clin Exp. 2020 Jun 15;92:100591
pubmed: 32714473
BMC Complement Altern Med. 2017 Feb 1;17(1):86
pubmed: 28143507
J Obstet Gynaecol. 2020 Jan;40(1):10-19
pubmed: 31215276
Complement Ther Med. 2019 Aug;45:114-123
pubmed: 31331547
Phytother Res. 2020 Aug;34(8):1723-1733
pubmed: 32147845
Phytomedicine. 2018 Nov 15;50:8-18
pubmed: 30466995
PLoS One. 2021 Feb 8;16(2):e0245163
pubmed: 33556053
J Clin Epidemiol. 2014 Apr;67(4):368-75
pubmed: 24581293
Obstet Gynecol. 2019 May;133(5):920-932
pubmed: 30969204